This book explores suicide prevention perspectives from around the world, considering both professionals’ points of view as well as first-person accounts from suicidal individuals. Scholars around the globe have puzzled over what makes a person suicidal and what is in the minds of those individuals who die by suicide. Most often the focus is not on the motives for suicide, nor on the phenomenology of this act, but on what is found from small cohorts of suicidal individuals. This book offers a tentative synthesis of a complex phenomenon, and sheds some light on models of suicide that are less frequently encountered in the literature. Written by international experts, it makes a valuable contribution to the field of suicidology that appeals to a wide readership, from mental health professionals to researchers in suicidology and students.

This book has been replaced by Managing Suicidal Risk, Third Edition, ISBN 978-1-4625-5269-6.

This book offers mental health clinicians a comprehensive guide to assessing and managing suicide risk. Suicide has now come to be understood as a multidimensionally determined outcome, which stems from the complex interaction of biological, genetic, psychological, sociological and environmental factors. Based on recent evidence and an extensive literature review, the book provides straightforward, essential information that can easily be applied in a wide variety of disciplines.

A practical and easy-to-use guide for healthcare professionals on the prevention, assessment and treatment of people at risk of suicide.

This volume is a guide for the hospital workforce related to suicide prevention. Written by experts in the field, this text is the only one that also includes the revised DSM-5 guidelines. It is also the first to cover both prevention in one concise guide, offering a well-rounded approach to long- and short-term prevention. The book begins by establishing the neurobiology of suicide before discussing the populations at risk for suicide and the various environments where they may present. The book addresses the epidemiology, including groups at heightened risk; etiology, including several types of risk factors; prevention, including large-scale community-based activities; and postvention, including the few evidence-based approaches that are currently available. Unlike any other text on the market, this book does not simply focus on one particular demographic; rather, the book covers a wide range of populations and concerns, including suicide in youths, racial minorities, patients suffering from serious mental and physical illnesses, psychopharmacological treatment in special populations, and a wide array of challenging scenarios that are often not addressed in the very few up-to-date resources available. Suicide Prevention is an outstanding resource for psychiatrists, psychologists, hospitalists, primary care doctors, nurses, social workers, and all medical professionals who may interface with suicidal patients.

With recent studies using genetic, epigenetic, and other molecular and neurochemical approaches, a new era has begun in understanding pathophysiology of suicide. Emerging evidence suggests that neurobiological factors are not only critical in providing potential risk factors but also provide a promising approach to develop more effective treatment and prevention strategies. The Neurobiological Basis of Suicide discusses the most recent findings in suicide neurobiology. Psychological, psychosocial, and cultural factors are important in determining the risk factors for suicide; however, they offer weak prediction and can be of little clinical use. Interestingly, cognitive characteristics are different among depressed suicidal and depressed nonsuicidal subjects, and could be involved in the development of suicidal behavior. The characterization of the neurobiological basis of suicide is in delineating the risk factors associated with suicide. The Neurobiological Basis of Suicide focuses on how and why these neurobiological factors are crucial in the pathogenic mechanisms of suicidal behavior and how these findings can be transformed into potential therapeutic applications.

Year in and year out, patient suicide tops The Joint Commission's list of sentinel events. If your healthcare organization admits and treats patients with psychiatric symptoms, National Patient Safety Goals require you to screen patients for suicide risk. In addition, the commission is now conducting a program-specific tracer on suicide assessment and prevention in applicable settings. Are you prepared?